Neurogene Inc. Common Stock (NASDAQ: NGNE) last traded at $26.40, down 0.38% on the session. The quote above updates while this page is open; the figures below are drawn from Neurogene Inc. Common Stock’s own filings and are restated only when a new one is published.
Neurogene Inc. Common Stock trades on NASDAQ under the ticker NGNE. Its market capitalisation is $528.30 million.
Valuation measures for Neurogene Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $528.30M |
|---|---|
| Enterprise value | $443.05M |
| Price / book | 2.43 |
| Beta | 1.47 |
Trailing-twelve-month figures tagged in Neurogene Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) |
|---|
| $0.00 |
| Net income (TTM) | -$111.11M |
|---|
| EPS (TTM) | -$5.03 |
|---|
| Return on equity | -51.17% |
|---|
| Cash | $112.48M |
|---|
Range and volume for NGNE over the past 52 weeks.
| 52-week high | $43.66 |
|---|---|
| 52-week low | $15.93 |
| Volume | 465.9K |
| Average volume | 250.5K |
| Previous close | $26.50 |
Invest a chosen dollar amount in Neurogene Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell NGNE.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.